secwatch / observer
8-K filed May 10, 2023, 7:59 PM ET ticker KRRO CIK 0001703647
leadership confidence high sentiment neutral materiality 0.30

Director Joel S. Marcus resigns from Frequency Therapeutics board effective May 5, 2023

Korro Bio, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joel S. Marcus

Director
KRRO · Korro Bio, Inc.
Effective
2023-05-05
Filed
May 10, 2023, 7:59 PM ET
On May 5, 2023, Joel S. Marcus notified Frequency Therapeutics, Inc. (the “Company”) of his resignation from the Company’s Board of Directors (the “Board”) and all committees of the Board on which he served, which was immediately effective.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joel S. Marcus resigned as Director at Korro Bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
On May 5, 2023, Joel S. Marcus notified Frequency Therapeutics, Inc. (the “Company”) of his resignation from the Company’s Board of Directors (the “Board”) and all committees of the Board on which he served, which was immediately effective.
View on SEC.gov

Korro Bio, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-140700
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.